Prism Pharmaceuticals Receives FDA Approval of Ready-to-Use Nexterone (Amiodarone HCl) Premixed Injection
Links shared publicly online about this topic.
- 708total visits
Prism Pharmaceuticals Receives FDA Approval of Ready-to-Use Nexterone (Amiodarone HCl) Premixed Injection
Nexterone (amiodarone HCl) is used to treat life-threatening ventricular fibrillation and ventricular tachycardia. Includes Nexterone side effects, interactions and indications.
View full resource at drugs.com
Tags: Arrhythmia, Ventricular Fibrillation, Drug, Pharma, FDA, Antiarrhythmic Medication, Cordarone
Most Recently Shared on November 22, 2010 at 10:07 pm By:
Prism Pharmaceuticals Receives FDA Approval of Ready-to-Use Nexterone (Amiodarone HCl) Premixed Injection:... http://bit.ly/e5xFxU #drug
Prism Pharmaceuticals Receives FDA Approval of Ready-to-Use Nexterone (Amiodarone HCl) Premixed Injection
drugs.com — “Nexterone (amiodarone HCl) is used to treat life-threatening ventricular fibrillation and ventricular tachycardia. Includes Nexterone side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 22, 2010 at 9:51 pm By:
FDA Approves Ready-to-Use Nexterone (Amiodarone HCl) Premixed Injection - http://bit.ly/eLpm0Y
Advertisement
